Dr. John C. Blackenburg, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 700 Dallas Ave, Selma, AL 36701 Phone: 850-622-0364 Fax: 850-622-0364 |
Mr. Leroy Maxwell Sr., OD MPH Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2401 Medical Center Pkwy, Selma, AL 36701 Phone: 334-872-2321 Fax: 334-872-2391 |
Primary Eyecare Center Llc Optometrist Medicare: Medicare Enrolled Practice Location: 801 Dallas Ave, Selma, AL 36701 Phone: 334-874-7024 Fax: 334-874-7372 |
Kristina Lovinggood, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 801 Dallas Ave, Selma, AL 36701 Phone: 334-874-7024 Fax: 334-874-7372 |
Selma Eye Associates, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 700 Dallas Ave, Selma, AL 36701 Phone: 334-872-6296 Fax: 334-872-5000 |
Dr. Jeffery B. Ford And Assoc. Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1501 Al Highway 14 E, Selma, AL 36703 Phone: 334-874-8357 |
Dr. Yolanda Taylor-rose, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2401 Medical Center Pkwy, Selma, AL 36701 Phone: 334-872-2321 Fax: 334-872-2391 |
Ashley R Williams, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 406 Dallas Ave, Selma, AL 36701 Phone: 334-878-2020 Fax: 334-878-2025 |
Preferred Eye Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 406 Dallas Ave, Selma, AL 36701 Phone: 334-878-2020 |
Eyemax Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 2401 Medical Center Pkwy, Selma, AL 36701 Phone: 334-872-2321 |
Dr. Jeffery B Ford & Assoc. Optometrist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1501 Al Highway 14 E, Selma, AL 36703 Phone: 334-230-9694 |
Wyatt- Kirkpatrick Eye Md Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2 Office Park Cir, Selma, AL 36701 Phone: 334-872-3403 Fax: 334-872-3405 |
News Archive
Celsion Corporation today announced that Dr. Ronnie T.P. Poon from the University of Hong Kong and lead principal investigator for the Asia Pacific region of the Phase I ThermoDox dose escalation trial will hold a press conference on Thursday, April 15, 2010 at 10:30 AM HKT (Wednesday, April 14, 2010 10:30 PM ET) to discuss the long-term follow-up of patients treated from April 2006 to December 2006.
Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).
If a drug can be guided to the right place in the body, the treatment is more effective and there are fewer side-effects. Researchers at Lund University in Sweden have now developed magnetic nanoparticles that can be directed to metallic implants such as artificial knee joints, hip joints and stents in the coronary arteries.
African American and Hispanic adolescents and young adults fare far worse than their white counterparts when faced with a mostly curable type of cancer, Hodgkin lymphoma, a study by a UC Davis epidemiologist has found.
Addressing the relentless game of cat and mouse played between antibiotics and bacteria, a pair of University of Houston professors recently received a $519,000 grant from the National Institutes of Health.
› Verified 7 days ago